LINC-PINT and ovarian carcinoma: Nasopharyngeal cancer, renal carcinoma, non-small cell lung cancer, glioblastoma, thyroid cancer, retinoblastoma, ovarian cancer, breast cancer, oesophageal squamous cell carcinoma, osteosarcoma, melanoma, and gastric cancer are among those in which LINC-PINT is downregulated.